These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26065717)

  • 1. Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract.
    Tsuda A; Suda W; Morita H; Takanashi K; Takagi A; Koga Y; Hattori M
    Clin Transl Gastroenterol; 2015 Jun; 6(6):e89. PubMed ID: 26065717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral microbiome alterations of healthy volunteers with proton pump inhibitor.
    Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary microbiota composition before and after use of proton pump inhibitors in patients with laryngopharyngeal reflux: a self-control study.
    Cui X; Yin L; Zhang Y; Jiang X; Li L; Bi X
    BMC Oral Health; 2024 Oct; 24(1):1194. PubMed ID: 39379876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the impact of commonly used medications on the oral microbiome of individuals living without major chronic conditions.
    DeClercq V; Nearing JT; Langille MGI
    PLoS One; 2021; 16(12):e0261032. PubMed ID: 34882708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study.
    Takagi T; Naito Y; Inoue R; Kashiwagi S; Uchiyama K; Mizushima K; Tsuchiya S; Okayama T; Dohi O; Yoshida N; Kamada K; Ishikawa T; Handa O; Konishi H; Okuda K; Tsujimoto Y; Ohnogi H; Itoh Y
    J Clin Biochem Nutr; 2018 Jan; 62(1):100-105. PubMed ID: 29371761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients.
    Wellhöner F; Döscher N; Tergast TL; Vital M; Plumeier I; Kahl S; Potthoff A; Manns MP; Maasoumy B; Wedemeyer H; Cornberg M; Pieper DH; Heidrich B
    Scand J Gastroenterol; 2019 Aug; 54(8):1033-1041. PubMed ID: 31361979
    [No Abstract]   [Full Text] [Related]  

  • 8. Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia.
    Igarashi M; Nakae H; Matsuoka T; Takahashi S; Hisada T; Tomita J; Koga Y
    BMJ Open Gastroenterol; 2017; 4(1):e000144. PubMed ID: 28761692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity and composition of the bacterial community in Amphioxus feces.
    Pan M; Yuan D; Chen S; Xu A
    J Basic Microbiol; 2015 Nov; 55(11):1336-42. PubMed ID: 26173442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of Duodenal and Rectal Microbiota in Biopsy Tissues and Luminal Contents in Healthy Volunteers.
    Li G; Yang M; Zhou K; Zhang L; Tian L; Lv S; Jin Y; Qian W; Xiong H; Lin R; Fu Y; Hou X
    J Microbiol Biotechnol; 2015 Jul; 25(7):1136-45. PubMed ID: 25737115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients.
    Lin YT; Lin TY; Hung SC; Liu PY; Wu PH; Chuang YS; Hung WC; Chiu YW; Kuo MC; Wu CY
    Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33573326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota Compartments.
    Shobar RM; Velineni S; Keshavarzian A; Swanson G; DeMeo MT; Melson JE; Losurdo J; Engen PA; Sun Y; Koenig L; Mutlu EA
    Clin Transl Gastroenterol; 2016 Feb; 7(2):e143. PubMed ID: 26866392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.
    Ratuapli SK; Ellington TG; O'Neill MT; Umar SB; Harris LA; Foxx-Orenstein AE; Burdick GE; Dibaise JK; Lacy BE; Crowell MD
    Am J Gastroenterol; 2012 May; 107(5):730-5. PubMed ID: 22334250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.
    Ringel Y; Maharshak N; Ringel-Kulka T; Wolber EA; Sartor RB; Carroll IM
    Gut Microbes; 2015; 6(3):173-81. PubMed ID: 25915459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and salivary microbiota associated with recurrent aphthous stomatitis.
    Kim YJ; Choi YS; Baek KJ; Yoon SH; Park HK; Choi Y
    BMC Microbiol; 2016 Apr; 16 Suppl 1():57. PubMed ID: 27036492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods.
    Eun CS; Kim BK; Han DS; Kim SY; Kim KM; Choi BY; Song KS; Kim YS; Kim JF
    Helicobacter; 2014 Dec; 19(6):407-16. PubMed ID: 25052961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An accurate and efficient experimental approach for characterization of the complex oral microbiota.
    Zheng W; Tsompana M; Ruscitto A; Sharma A; Genco R; Sun Y; Buck MJ
    Microbiome; 2015 Oct; 3():48. PubMed ID: 26437933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the fecal bacteria communities of forage-fed horses by pyrosequencing of 16S rRNA V4 gene amplicons.
    Shepherd ML; Swecker WS; Jensen RV; Ponder MA
    FEMS Microbiol Lett; 2012 Jan; 326(1):62-8. PubMed ID: 22092776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between chronic treatment with proton pump inhibitors and bacterial overgrowth in the stomach: any possible beneficial role for selected lactobacilli?
    Del Piano M; Pagliarulo M; Tari R; Carmagnola S; Balzarini M; Lorenzini P; Pane M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S40-6. PubMed ID: 25291126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial overgrowth and diversification of microbiota in gastric cancer.
    Wang L; Zhou J; Xin Y; Geng C; Tian Z; Yu X; Dong Q
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):261-6. PubMed ID: 26657453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.